Influencing national policies on cardiovascular disease, and focusing on the best evidence-based secondary prevention treatment of heart disease and stroke

The Champion Advocates Programme is a World Heart Federation (WHF) initiative, originally supported by an unrestricted educational grant from AstraZeneca. It has been established to help achieve the globally agreed target of 25% reduction in premature mortality from non-communicable diseases (NCDs) by 2025. It aims to promote a global focus on cardiovascular disease (CVD), including heart disease and stroke, by creating CVD Champion Advocates among the following target groups:

Cardiologists and other healthcare professionals

Focusing on the best evidence-based secondary prevention treatment of heart disease and stroke to prolong the life of patients. Champion Advocates will be encouraged to support the accelerated implementation of secondary prevention guidelines within hospitals, medical practices and clinics.


Building media awareness around heart health, and primary and secondary prevention, and briefing journalists to improve coverage of CVD prevention and treatment. This will support public messages that many CVD-related deaths are preventable with appropriate interventions and timely medical support. Through media outreach, we also aim to positively influence national health policies in support of the global 2025 targets.

Emerging leaders

Developing a cadre of emerging leaders to influence and strengthen a whole-of-society response to CVD prevention and treatment across the globe.

To register to join the WHF Champion Advocates Programme today and start accessing useful resources and information specially developed for healthcare professionals and journalists, please click here.